These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11981091)

  • 1. High dose of bolus iron vs. low dose of weekly infusion: bolusing high dose, a recipe for iron toxicity?
    Salahudeen AK
    Nephrol Dial Transplant; 2002 May; 17(5):939-40; author reply 940. PubMed ID: 11981091
    [No Abstract]   [Full Text] [Related]  

  • 2. Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.
    Hedenus M; Birgegård G; Näsman P; Ahlberg L; Karlsson T; Lauri B; Lundin J; Lärfars G; Osterborg A
    Leukemia; 2007 Apr; 21(4):627-32. PubMed ID: 17252006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
    Wali YA; Taqi A; Deghaidi A
    Pediatr Hematol Oncol; 2004; 21(5):453-60. PubMed ID: 15205089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment with low doses of intravenous iron does not modify hemoglobin nor the erythropoietin dosage].
    Fernández-Gallego J; Martín MA; Alonso A; Toledo R
    Nefrologia; 2006; 26(1):143-4. PubMed ID: 16649439
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous iron for the treatment of anemia in a day hospital: between inflammation and bleeding].
    Méndez Bailón M; Muñoz Rivas N
    Gastroenterol Hepatol; 2010 Dec; 33(10):755-6. PubMed ID: 21051114
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha.
    Greenblatt MS; Mangalik A; Ferguson J; Elias L
    Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of frequency of intravenous iron administration on hemoglobin variability in maintenance hemodialysis patients.
    Wan L; Zhang D
    Int Urol Nephrol; 2018 Aug; 50(8):1511-1518. PubMed ID: 29946818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer.
    Toussaint C; Izzo J; Spielmann M; Merle S; May-Levin F; Armand JP; Lacombe D; Tursz T; Sunderland M; Chabot GG
    J Clin Oncol; 1994 Oct; 12(10):2102-12. PubMed ID: 7931480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective crossover trial comparing intermittent intravenous and continuous oral iron supplements in peritoneal dialysis patients.
    Johnson DW; Herzig KA; Gissane R; Campbell SB; Hawley CM; Isbel NM
    Nephrol Dial Transplant; 2001 Sep; 16(9):1879-84. PubMed ID: 11522873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous iron treatment in the puerperium.
    Holm C
    Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis.
    Salahudeen AK; Oliver B; Bower JD; Roberts LJ
    Kidney Int; 2001 Oct; 60(4):1525-31. PubMed ID: 11576368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety profile of iron polymaltose infusions.
    Lee AYS; Leung SHP
    Hosp Pract (1995); 2019 Apr; 47(2):96-98. PubMed ID: 30882255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose 5-fluorouracil / folinic acid in combination with three-weekly mitomycin C in the treatment of advanced gastric cancer. A phase II study.
    Hofheinz RD; Hartung G; Samel S; Hochhaus A; Pichlmeier U; Post S; Hehlmann R; Queisser W
    Onkologie; 2002 Jun; 25(3):255-60. PubMed ID: 12119460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of iron deficiencies].
    Waller HD
    Verh Dtsch Ges Inn Med; 1978; (84):78-89. PubMed ID: 369210
    [No Abstract]   [Full Text] [Related]  

  • 16. Controversial issues in 5-fluorouracil infusion use. Dose intensity, treatment duration, and cost comparisons.
    Anderson N; Lokich J
    Cancer; 1992 Aug; 70(4 Suppl):998-1002. PubMed ID: 1638471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical use of intravenous iron: administration, efficacy, and safety.
    Auerbach M; Ballard H
    Hematology Am Soc Hematol Educ Program; 2010; 2010():338-47. PubMed ID: 21239816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose infusional 5-FU in the treatment of advanced colorectal cancer: a summary of the European experience.
    Wils JA
    J Infus Chemother; 1996; 6(3):145-8. PubMed ID: 9229327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral iron nephrotoxicity: potential mechanisms and consequences.
    Zager RA; Johnson AC; Hanson SY
    Kidney Int; 2004 Jul; 66(1):144-56. PubMed ID: 15200421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.